{"id":"abbv-cls-628","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"S1P1 receptor antagonists like ABBV-CLS-628 are being investigated for their potential to treat multiple sclerosis and other autoimmune diseases by inhibiting the S1P1 receptor, which plays a key role in the migration of immune cells.","oneSentence":"ABBV-CLS-628 is a small molecule targeting the S1P1 receptor.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:28:17.412Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relapsing multiple sclerosis"}]},"trialDetails":[{"nctId":"NCT06902558","phase":"PHASE2","title":"A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-06-09","conditions":"Autosomal Dominant Polycystic Kidney Disease","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ABBV-CLS-628","genericName":"ABBV-CLS-628","companyName":"AbbVie","companyId":"abbvie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ABBV-CLS-628 is a small molecule targeting the S1P1 receptor. Used for Relapsing multiple sclerosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}